Montana researchers are working to develop a more effective tuberculosis (TB) vaccine, improving on the existing BCG vaccine which is only 40-80% effective in young children and less effective in adults and adolescents. Novel adjuvants are being added to the vaccine in a process called precision vaccination. The project, which has been in progress for 15 years, anticipates another five years before the vaccine may be widely distributed.
Lawmakers slam UnitedHealth handling of Change cyberattack amid lingering impact on physician practices
Sen. Mike Crapo (R-Idaho) criticized delays in response to a cyber attack on health care service provider Change. The company processes $1.5tn in medical claims
